Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AS +11.5%, XYF +11.3%, PONY +5.9%, BILI +4.9%, TRNS +4.3%, SB +4%, CI +2.5% (guidance), HD +2.3%, BWLP +1.6%, AGYS +1.2%, EGHT +1.1%
Other news:
- ASPI +13.4% (deal with terraPower including loan agreement for construction of a HALEU production facility and supply agreements for HALEU; will host an investor webcast starting at 8:00 a.m. EST on Tuesday, May 20)
- QBTS +8.9% (announces availability of Advantage2 Quantum Computer)
- PEGA +6.8% (to join S&P MidCap 400)
- VRRM +3.1% (authorizes new $100 mln share repurchase program)
- INVA +2% (announced the United States commercial availability of ZEVTERA)
- PPTA +1.8% (receives final federal permit for Stibnite Gold Project)
- SNDX +1.8% (discloses several insider buys)
- ZYME +1.5% (presents preclinical data on ZW1528)
- NNE +1.5% (NANO Nuclear Energy and and MIT's Department of Nuclear Science and Engineering Launch advanced irradiation study to investigate salt-based thermal storage for nuclear applications)
- TRML +1.3% (to present topline results from Phase 2 trial)
- PFE +1.1% (enters into exclusive licensing agreement with 3SBio)
- ANNX +1% (showcases tanruprubart data)
- ZK +1% (Special Committee retains legal and financial advisors)
- TRVI +0.9% (announces additional analyses from phase 2a RIVER trial of Haduvio in patients with refractory chronic cough)